Search Results - "CONTER, Valentino"
-
1
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
Published in Bone marrow transplantation (Basingstoke) (01-10-2020)“…Italy is the second exposed country worldwide, after China, and Lombardia is the most affected region in Italy, with more than half of the national cases, with…”
Get full text
Journal Article -
2
Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
Published in Haematologica (Roma) (01-02-2022)Get full text
Journal Article -
3
BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
Published in Haematologica (Roma) (01-09-2020)Get full text
Journal Article -
4
Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
Published in The New England journal of medicine (12-04-2012)“…Induction chemotherapy fails to induce a complete remission in only about 2 to 3% of children with ALL. In an analysis of more than 1000 such patients, the…”
Get full text
Journal Article -
5
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Published in Blood (28-04-2016)“…Induction therapy for childhood acute lymphoblastic leukemia (ALL) traditionally includes prednisone; yet, dexamethasone may have higher antileukemic potency,…”
Get full text
Journal Article -
6
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)
Published in Journal of clinical oncology (20-01-2018)“…Purpose Delayed intensification (DI) is an integral part of treatment of childhood acute lymphoblastic leukemia (ALL), but it is associated with relevant…”
Get full text
Journal Article -
7
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
Published in Haematologica (Roma) (01-01-2022)“…Antibodies against polyethylene glycol (PEG) in healthy subjects raise concerns about the efficacy of pegylated drugs. We evaluated the prevalence of…”
Get full text
Journal Article -
8
Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
Published in Journal of clinical oncology (01-11-2009)“…Speed of blast clearance is an indicator of outcome in childhood acute lymphoblastic leukemia (ALL). Availability of measurement of minimal residual disease…”
Get full text
Journal Article -
9
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
Published in Haematologica (Roma) (01-01-2018)“…The prognostic value of minimal residual disease (MRD) in Philadelphia-chromosome-positive (Ph+) childhood acute lymphoblastic leukemia (ALL) treated with…”
Get full text
Journal Article -
10
Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence
Published in Frontiers in oncology (31-07-2024)“…The incorporation of tyrosine kinase inhibitors (TKIs) in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) led to…”
Get full text
Journal Article -
11
-
12
Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
Published in Journal of clinical oncology (01-11-2010)“…In a previous analysis of 326 children with Philadelphia chromosome (Ph) -positive acute lymphoblastic leukemia (ALL) treated between 1986 and 1996,…”
Get full text
Journal Article -
13
Collateral effects of COVID‐19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay
Published in Pediatric blood & cancer (01-08-2020)Get full text
Journal Article -
14
-
15
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Published in Haematologica (Roma) (01-07-2020)“…ABL-class fusions other than characterize around 2-3% of precursor B-cell acute lymphoblastic leukemia. Case series indicated that patients suffering from…”
Get full text
Journal Article -
16
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Published in Haematologica (Roma) (01-12-2023)“…Although initial central nervous system (CNS) involvement is rarely detected in childhood acute lymphoblastic leukemia (ALL), risk-adapted CNS-directed therapy…”
Get full text
Journal Article -
17
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
Published in Haematologica (Roma) (01-11-2013)“…The outcome of children and adults with acute lymphoblastic leukemia is markedly different. Since there is limited information on the distribution of…”
Get full text
Journal Article -
18
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
Published in Haematologica (Roma) (01-09-2019)“…Asparagine levels in cerebrospinal fluid and serum asparaginase activity were monitored in children with acute lymphoblastic leukemia treated with…”
Get full text
Journal Article -
19
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study
Published in Blood (06-03-2014)“…The outcome of high-risk (HR) acute lymphoblastic leukemia patients enrolled in the AIEOP-BFM ALL 2000 study in Italy is described. HR criteria were minimal…”
Get full text
Journal Article -
20